The organization of a Center for the diagnosis and treatment of breast tumors on the basis of the state regional oncological center
- 作者: Voroshina N.V.1, Vazhenin A.V.2, Domozhirova A.S.3
-
隶属关系:
- deputy chief of the Chelyabinsk Regional Clinical Center for Oncology and Nuclear Medicine, Chelyabinsk, 454087, Russia
- Chelyabinsk Regional Center of Oncology and Nuclear Medicine
- Russian Scientific Center of Roentgenoradiology
- 期: 卷 64, 编号 2 (2020)
- 页面: 61-67
- 栏目: HEALTH CARE ORGANIZATION
- ##submission.dateSubmitted##: 25.10.2024
- URL: https://hum-ecol.ru/0044-197X/article/view/637518
- DOI: https://doi.org/10.46563/0044-197X-2020-64-2-61-67
- ID: 637518
如何引用文章
全文:
详细
Introduction. In the current environmental situation in Russia, the organization of early detection of cancer in women of fertile age is of particular importance, which has medical, social and demographic consequences. Among malignant neoplasms in women - breast cancer takes the first place in the Russian Federation. 30% of the cases are women of working age. The increase in the incidence of breast cancer in the Chelyabinsk region from 2008 to 2018 was about 30%. In 2018, the proportion of stage I-II breast cancer is 67.5%. To improve the quality of specialized medical care for patients with suspected and/or established breast cancer on the basis of the state medical institution «Chelyabinsk regional clinical center of Oncology and nuclear medicine» in 2018, a center for diagnosis and treatment of breast tumors (hereinafter - the Center) was established.
Purpose of work. Analysis of the first results of the Center’s work.
Materials and methods. Patients referred for consultation to the Center from 01.11.2018 to 31.08.2019.
Results. As a result of the work of the Center for 10 months, there was a reduction in the time of examination of patients with suspected breast cancer from 30 to 14 calendar days. The share of detected breast cancer in the region at localized stages for 10 months of 2019 was higher (69.5%) compared to the same period of 2018 (66.7%), which is based on an increase in active detection of pathology in the established Center.
Discussion. The creation of the Center has increased the availability of specialized care for patients with breast pathology. Reduced time for examination and conduct of trepan-biopsy of the tumor to confirm the diagnosis. Patients with breast cancer have a personalized approach to the treatment program.
Conclusion. The establishment of the Center allows to improve the quality of specialized medical care for patients with suspected and/or established breast cancer.
作者简介
N. Voroshina
deputy chief of the Chelyabinsk Regional Clinical Center for Oncology and Nuclear Medicine, Chelyabinsk, 454087, Russia
编辑信件的主要联系方式.
Email: natalyavoroshina67@gmail.com
ORCID iD: 0000-0003-0793-6867
A. Vazhenin
Chelyabinsk Regional Center of Oncology and Nuclear Medicine
Email: noemail@neicon.ru
ORCID iD: 0000-0002-7807-8479
俄罗斯联邦
A. Domozhirova
Russian Scientific Center of Roentgenoradiology
Email: noemail@neicon.ru
ORCID iD: 0000-0003-0806-3164
俄罗斯联邦
参考
- GLOBOCAN 2012v1.0 Cancer Incidence and Mortality Worldwide: IARC Cancer Base №11. Lyon, France: International Agency for Research on Cancer; 2013. Available at: https://gco.iarc.fr/
- Bray F., McCarron P., Parkin D.M. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res. 2004; 6(6): 229-39. https://doi.org/10.1186/bcr932
- Аксенова И.А., Новикова Т.С. Особенности заболеваемости раком молочной железы женского населения Челябинской области с учетом этнических различий. В кн.: Материалы XV итоговой научно-практической конференции молодых ученых и специалистов. Челябинск; 2017: 10-3.
- Каприн А.Д., Старинский В.В., Петрова Г.В., ред. Состояние онкологической помощи населению России в 2017 году. М.; 2018.
- Важенин А.В., Доможирова А.С., Аксенова И.А., Ратнер Е.В., ред. Эпидемиологические особенности онкологической ситуации и показатели состояния онкологической помощи населению в Челябинской области в 2018 году. Статистический сборник. Челябинск; 2019.
- Мазо М.Л., Рожкова Н.И., Добровольская Н.Ю. Диагностика и лечение рака молочной железы. Ремедиум Приволжье. 2018; (1): 32-6.
- Мерабишвили В.М. Выживаемость онкологических больных. СПб.; 2011: 178, 261-4.
- Божок А.А., Топузов Э.Э., Зикиряходжаев А.Д., Сухотько А.С., Хайленко В.А., Шатова Ю.С. и др. Возможности хирургического лечения рака молочной железы IV стадии. Опухоли женской репродуктивной системы. 2016; 12(4): 17-24. https://doi.org/10.17650/1994-4098-2016-12-4-17-24
- Поддубная И.В., Колядина И.В., Колашников Н.Д., Борисов Д.А., Макарова М.В. Популяционный портрет рака молочной железы в России: анализ российского регистра. Современная онкология. 2015; 17(1): 25-9.
- Синкина Т.В., Петрова В.Д., Лазарев А.Ф. Современные представления о факторах риска рака молочной железы. Российский биотерапевтический журнал. 2009; 8(1): 88-94.
- Федоров Н.М., Наумов М.М., Павлова В.И., Царев О.Н., Подгальная Е.Б., Налетов А.А. и др. Актуальные аспекты вторичной профилактики рака молочной железы в Тюменской области. Тюменский медицинский журнал. 2015; 17(3): 29-32.
补充文件
